Impact of PCSK9, WDR12, CDKN2A, and CXCL12 Polymorphisms in Jordanian Cardiovascular Patients on Warfarin Responsiveness and Sensitivity

BACKGROUND: The main objective of this study is sought to determine the impacts of PCSK9, WDR12, CDKN2A, and CXCL12 polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and stabilization phases of therapy. METHODS: This study took place...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Gen Med
Auteurs principaux: Ibdah, Rasheed K, AL-Eitan, Laith N, Alrabadi, Nasr N, Almasri, Ayah Y, Alnaamneh, Adan H, Khasawneh, Rame H, Alghamdi, Mansour A
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7814275/
https://ncbi.nlm.nih.gov/pubmed/33488114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S287238
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires